These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Guidelines for clinical use of drugs for involutional osteoporosis]. Yamamoto I Nihon Rinsho; 1998 Jun; 56(6):1499-504. PubMed ID: 9648472 [TBL] [Abstract][Full Text] [Related]
24. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis. Murray TM CMAJ; 1996 Oct; 155(7):935-9. PubMed ID: 8837543 [TBL] [Abstract][Full Text] [Related]
25. [Pharmacotherapy of osteoporosis: evidence-based clinical practice]. Fassbender WJ; Stumpf UC; Jockenhövel F Med Klin (Munich); 2006 Mar; 101 Suppl 1():173-7. PubMed ID: 16802548 [TBL] [Abstract][Full Text] [Related]
26. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis]. Suzuki Y; Sato S Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275 [TBL] [Abstract][Full Text] [Related]
27. Osteoporosis prevention and treatment. Sambrook PN; Eisman JA Med J Aust; 2000 Mar; 172(5):226-9. PubMed ID: 10776395 [TBL] [Abstract][Full Text] [Related]
28. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients. McClune BL; Polgreen LE; Burmeister LA; Blaes AH; Mulrooney DA; Burns LJ; Majhail NS Bone Marrow Transplant; 2011 Jan; 46(1):1-9. PubMed ID: 20729922 [TBL] [Abstract][Full Text] [Related]
29. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Fracture risk assessment with Japanese guideline]. Hosoi T Clin Calcium; 2008 Aug; 18(8):1084-8. PubMed ID: 18677044 [TBL] [Abstract][Full Text] [Related]
30. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143 [TBL] [Abstract][Full Text] [Related]
31. [A guide for osteoporosis management]. Zárate A; Saucedo R; Basurto L Gac Med Mex; 2004; 140(2):235-40. PubMed ID: 15162957 [TBL] [Abstract][Full Text] [Related]
32. The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause. Tham YL; Sexton K; Weiss HL; Elledge RM; Friedman LC; Kramer RM J Support Oncol; 2006 Jun; 4(6):295-8, 304. PubMed ID: 16805332 [TBL] [Abstract][Full Text] [Related]
33. [Recommendations of the Croatian Society for Rheumatology for prevention, diagnostics and treatment of post-menopausal osteoporosis]. Curković B; Grazio S; Babić-Naglić D; Anić B; Vlak T; Hanih M; Reumatizam; 2008; 55(1):26-30. PubMed ID: 19024267 [TBL] [Abstract][Full Text] [Related]
34. [Absolute risk for fracture and WHO guideline. Fracture risk assessments recommended by World Health Organization and Japanese guidelines for prevention and treatment of osteoporosis 2006]. Nakamura T; Clin Calcium; 2007 Jul; 17(7):1022-8. PubMed ID: 17607068 [TBL] [Abstract][Full Text] [Related]
35. Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation. Czerwiński E; Badurski JE; Marcinowska-Suchowierska E; Osieleniec J Ortop Traumatol Rehabil; 2007; 9(4):337-56. PubMed ID: 17882114 [TBL] [Abstract][Full Text] [Related]
36. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. De Nijs RN Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694 [TBL] [Abstract][Full Text] [Related]
37. [The Diagnosis and Treatment of Osteoporosis]. Kageyama G Rinsho Byori; 2015 May; 63(5):570-9. PubMed ID: 26524896 [TBL] [Abstract][Full Text] [Related]